MedTech Startup's Regulated Market Entry into Japan

24 monthsIndustry Average$8MProjected Year-2 Revenue5Distribution Partners Screened

客户简介

A Singapore-based medical device startup with FDA-cleared products seeking PMDA approval for the Japanese market.

面临的挑战

Japan's medical device regulatory framework (PMDA) is one of the most complex globally. The startup had no Japanese-language documentation, no local regulatory affairs team, and no relationships with Japanese distributors.

我们的方法

Nirji assembled a local regulatory affairs team, managed the PMDA pre-submission consultation, coordinated clinical data translation and localisation, and identified 5 potential distribution partners through our Japanese network.

交付的解决方案

Secured PMDA approval within 14 months (vs. 24-month industry average), signed an exclusive distribution agreement with a top-3 Japanese medical device distributor, and projected $8M in Year-2 Japan revenue.

所有可衡量的成果

14 months

PMDA Approval Timeline

24 months

Industry Average

$8M

Projected Year-2 Revenue

Distribution Partners Screened

"Japan was our most challenging market entry. Nirji's regulatory expertise and local relationships made it possible."

本次合作中使用的服务

本案例研究涉及Nirji的以下能力。

Go-to-Market Strategy Consulting

Many promising products fail to gain traction not due to lack of quality, but because of an ill-defined go-to-market strategy. Businesses often miside...

了解更多

这与我们更广泛的实践有何关联

本次合作展示了 Nirji Ventures 如何整合多种能力以交付端到端的结果。面临类似挑战的公司通常受益于我们针对复杂决策的战略咨询实践、针对运营改进的业务转型咨询以及针对结构和治理的财务咨询。

对于寻求国际扩张的公司，我们的全球扩张咨询可在30多个国家提供市场准入支持。早期阶段的企业可以探索我们的初创企业咨询实践，以获得从种子前到B轮融资的战略指导。

浏览我们的洞察文库，获取关于早期初创企业增长策略、融资阶段、投资者评估标准和退出规划的研究和框架。查看所有案例研究以了解更多我们的工作实例。

Have a Similar Challenge?

Let's discuss how Nirji can help you achieve similar results.

Discuss a Similar Engagement